| Symbol | NEO |
|---|---|
| Name | NEOGENOMICS INC |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Services-Testing Laboratories |
| Address | 9490 NEOGENOMICS WAY, FORT MYERS, FL 33912 |
| Telephone | 2397680600 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001077183 |
| Description | None |
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
Read moreDirector Starrett Carolyn S 🟢 acquired 23.9K shares (2 derivative) of NEOGENOMICS INC (NEO) at $11.20 Transaction Date: Jun 23, 2026 | Filing ID: 045501
Read moreNew Form 3 - NEOGENOMICS INC <b>Filed:</b> 2026-06-25 <b>AccNo:</b> 0001628280-26-045499 <b>Size:</b> 418 KB
Read more(70% Positive) NEOGENOMICS INC (NEO) Announces Clinical Development Update
Read moreDirector TETRAULT LYNN A. 🔴 sold 89.6K shares (10 derivative) of NEOGENOMICS INC (NEO) at $41.76 Transaction Date: Jun 15, 2026 | Filing ID: 043875
Read moreNeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
Read more